The In vivo toxicology Market Size  was valued at USD 4.95 billion in 2024. It is projected to grow to USD 7.66 billion by 2032, at a CAGR of about 5.6%. The growth in this market is driven by increased research and development in pharmaceuticals and biotech, a rising demand for preclinical safety testing, and stricter global regulations. The increasing number of chronic diseases is also pushing drug development, which heightens the need for in vivo studies. Furthermore, improvements in animal models and the growth of contract research organizations (CROs) are making toxicology testing more accessible and efficient worldwide.

Recent Launches in the U.S. Market: At the 2025 SOT Annual Meeting, Taconic Biosciences showcased the rasH2™ transgenic mouse model. This model follows the new ICH S1B(R1) guidelines. It is particularly highlighted for carcinogenicity testing. The updated guidance reduces the dependence on long-term rodent studies for specific endpoints. The rasH2™ mouse offers a quicker and more resource-efficient method for assessing carcinogenic risk.

Download your Sample Report Instantly - Corporate Email ID required for priority access:https://www.datamintelligence.com/download-sample/in-vivo-toxicology-market?oppj 

Market Segmentation:

  -By product type:-  The market includes kits, reagents, and instruments. Kits currently hold a significant share of about 39.7%. These products are essential tools used in various toxicology tests to assess the safety of drugs and chemicals. 

  -By test type:-  The market consists of acute toxicity testing, sub-acute toxicity testing, sub-chronic toxicity testing, and chronic toxicity testing. Each type of test is important for evaluating the effects of substances over different exposure times. 

  -By technology:-  The market includes techniques such as in vivo imaging, in silico models, and omics technologies. These methods improve the accuracy and efficiency of toxicology assessments. 

  -By end user:- Pharmaceutical and biotechnology companies have the highest demand for in vivo toxicology services. They are followed by contract research organizations (CROs) and academic and research institutions. All these groups rely on toxicology data to ensure safety and compliance.

Market Drivers:- 

  -The in vivo toxicology market is expanding because of increased research and development in the pharmaceutical and biotech industries. As companies create new

drugs and therapies, thorough safety testing through in vivo studies is crucial to identify possible risks early.

  -Strict rules from agencies like the FDA and EMA also promote market growth by requiring detailed toxicology evaluations before products can be approved. Additionally, the rising number of chronic diseases worldwide has increased the need for innovative treatments, which raises the demand for thorough safety assessments.

  -Improvements in animal models and testing technologies have made toxicology studies more accurate and efficient. The growing trend of outsourcing these studies to Contract Research Organizations (CROs), particularly in cost-effective areas like Asia-Pacific, has made in vivo toxicology services easier to access, which supports further market growth.

 Speak to Our Senior Analyst and Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/in-vivo-toxicology-market?oppj 

Key Market Players:- 

  -Charles River Laboratories

  -Thermo Fisher Scientific

  -Labcorp Drug Development

  -Eurofins Scientific

  -WuXi AppTec

  -Danaher Corporation

  -Envigo

  -The Jackson Laboratory

  -PerkinElmer

  -SRI International

Recent Developments in 2025:- 

  -Technological Innovations: Advancements in humanized animal models and in vitro-to-in vivo extrapolation (IVIVE) methods are enhancing the accuracy and ethical considerations of toxicology studies. These innovations facilitate better predictions of human toxicity, reducing reliance on traditional animal testing.

  -Regulatory Support: In July 2025, the U.S. FDA launched the New Alternative Methods Program, allocating $5 million to promote non-animal testing methods. This initiative aims to replace, reduce, and refine animal use in regulatory assessments, reflecting a significant shift towards alternative testing methodologies. 

  -Market Growth: The global in vivo toxicology market is projected to reach USD 18.62 billion by 2032, growing at a CAGR of 11.58% from 2025 to 2032. This growth is attributed to the rising demand for drug safety testing, increased regulatory compliance for preclinical studies, and the expanding outsourcing of toxicity assessments by pharmaceutical and biotech firms. 

These developments indicate a dynamic and evolving landscape in the in vivo toxicology market, driven by technological innovations, regulatory support, and a growing emphasis on ethical considerations in scientific research.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=in-vivo-toxicology-market?oppj

Benefits Of the Report:-

  -Informed Decision-Making: The report provides detailed market analysis. It helps pharmaceutical companies, CROs, and investors make data-driven decisions to take advantage of emerging opportunities.

  -Competitive Landscape Understanding: The report highlights key players, recent developments, and technological advancements. This information enables businesses to compare themselves and stay ahead of competitors.

  -Market Trend Identification: By tracking current trends and future forecasts, the report helps stakeholders anticipate market shifts and adjust their strategies.

  -Regulatory Insights: Understanding changing regulatory frameworks helps companies ensure compliance and make their drug development and safety testing processes more efficient.

  -Investment Guidance: Investors and financial analysts get a clearer view of growth potential and risks in the in vivo toxicology market. This information supports better investment choices.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

 Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

Conclusion-

The in vivo toxicology market is undergoing a period of significant transformation, driven by rising demand for safer pharmaceuticals, stringent regulatory requirements, and rapid technological advancements. As the industry moves toward more ethical, efficient, and predictive toxicology methods, innovations such as humanized animal models, IVIVE techniques, and supportive regulatory programs are reshaping the landscape. With increasing R&D investments and the growing role of contract research organizations (CROs), the market is poised for steady growth over the coming years.

Contact Information 

Company: DataM Intelligence 

Contact Person: Sai Kiran 

Email: Sai.k@datamintelligence.com 

Phone: +1 877 441 4866 

Website: https://www.datamintelligence.com